Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Am J Hematol
    September 2021
  1. YE L, Jing L, Guo J, Zhao X, et al
    Red Blood Cell Lifespan is Reduced in Severe Aplastic Anemia and Improves with Response to Immunosuppressive Treatment.
    Am J Hematol. 2021 Sep 2. doi: 10.1002/ajh.26344.
    >> Share

    August 2021
  2. PEREZ BOTERO J, Reese JA, George JN, McIntosh JJ, et al
    Severe Thrombocytopenia and Microangiopathic Hemolytic Anemia in Pregnancy: A Guide for the Consulting Hematologist.
    Am J Hematol. 2021 Aug 23. doi: 10.1002/ajh.26328.
    >> Share

  3. DEXTER D, Layton DM, Kiritkumar K, Bain BJ, et al
    Peripheral blood features of iron overload in post-splenectomy, type I congenital dyserythropoietic anemia.
    Am J Hematol. 2021 Aug 20. doi: 10.1002/ajh.26327.
    >> Share

  4. SHIMANO KA, Narla A, Rose MJ, Gloude NJ, et al
    Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.
    Am J Hematol. 2021 Aug 3. doi: 10.1002/ajh.26310.
    >> Share

  5. PEREZ-LAMAS L, Moreno-Jimenez G, Tenorio-Nunez MC, Velazquez-Kennedy K, et al
    Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
    Am J Hematol. 2021;96:E288-E291.
    >> Share

  6. BOU-FAKHREDIN R, Daadaa H, Koussa S, Abou Nasr T, et al
    SARS-CoV-2 infection in patients with beta-thalassemia: Experience from Lebanon.
    Am J Hematol. 2021;96:E285-E288.
    >> Share

    July 2021
  7. HANSEN DL, Berentsen S, Fattizzo B, Hansen PL, et al
    Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy.
    Am J Hematol. 2021;96:E262-E265.
    >> Share

  8. WAHEED A, Kuter DJ
    Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria.
    Am J Hematol. 2021;96:E235-E237.
    >> Share

  9. MONTALBAN-BRAVO G, Kanagal-Shamanna R, Darbaniyan F, Siddiqui MT, et al
    Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS).
    Am J Hematol. 2021;96:E246-E249.
    >> Share

  10. KULASEKARARAJ AG, Brodsky RA, Hill A
    Monitoring of patients with paroxysmal nocturnal hemoglobinuria on a complement inhibitor.
    Am J Hematol. 2021;96:E232-E235.
    >> Share

    June 2021
  11. GURUNG K, Bain BJ
    A normal mean cell volume does not exclude a diagnosis of megaloblastic anemia.
    Am J Hematol. 2021 Jun 24. doi: 10.1002/ajh.26283.
    >> Share

  12. KIRK SE, Scheurer ME, Bernhardt MB, Mahoney DH, et al
    Phosphorus levels in children treated with intravenous ferric carboxymaltose.
    Am J Hematol. 2021;96:E215-E218.
    >> Share

  13. PANAGIOTA V, Meggendorfer M, Kubasch AS, Gabdoulline R, et al
    Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
    Am J Hematol. 2021;96:E207-E210.
    >> Share

  14. ZHANG X, Yang Y, Zhang H, Du Z, et al
    A rare complex rearrangement in the beta-globin gene cluster causing a novel homozygous (G) gamma((A) gammadeltabeta)(0) -thalassemia.
    Am J Hematol. 2021;96:E189-E193.
    >> Share

    May 2021
  15. RAMIREZ MJ, Pujol R, Trujillo-Quintero JP, Minguillon J, et al
    Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
    Am J Hematol. 2021 May 13. doi: 10.1002/ajh.26234.
    >> Share

  16. KIM SJ, Song J, Reading NS, Lautersztain J, et al
    Novel mechanism of hereditary pyropoikilocytosis phenotype due to co-inheritance of beta globin and alpha spectrin mutations.
    Am J Hematol. 2021;96:E150-E154.
    >> Share

  17. KALANTAR-ZADEH K, Ganz T, Trumbo H, Seid MH, et al
    Parenteral iron therapy and phosphorus homeostasis: A review.
    Am J Hematol. 2021;96:606-616.
    >> Share

  18. BAIN BJ
    Alpha chain inclusions in peripheral blood erythroblasts and erythrocytes.
    Am J Hematol. 2021;96:630-631.
    >> Share

    April 2021
  19. MAQUET J, Lafaurie M, Walter O, Sailler L, et al
    Epidemiology of autoimmune hemolytic anemia: a nationwide population-based study in France.
    Am J Hematol. 2021 Apr 30. doi: 10.1002/ajh.26213.
    >> Share

  20. BARCELLINI W, Zaninoni A, Giannotta JA, Merati G, et al
    Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias.
    Am J Hematol. 2021;96:E129-E132.
    >> Share

  21. MINNITI CP, Knight-Madden J, Tonda M, Gray S, et al
    The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease.
    Am J Hematol. 2021;96:E126-E128.
    >> Share

  22. AL-ALI AK, Alsulaiman A, Alfarhan M, Safaya S, et al
    Sickle cell disease in the Eastern Province of Saudi Arabia: Clinical and laboratory features.
    Am J Hematol. 2021;96:E117-E121.
    >> Share

  23. MCGRATH M, Quint EH, Weyand AC
    Depression in adolescents and young adults with heavy menstrual bleeding in a referral clinic setting.
    Am J Hematol. 2021;96:E105-E108.
    >> Share

  24. ARCHULETA J, van der Graaf M, Kaptein FHJ, Althaus L, et al
    Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease.
    Am J Hematol. 2021;96:E100-E102.
    >> Share

  25. OSUNKWO I, Andemariam B, Minniti CP, Inusa BPD, et al
    Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Am J Hematol. 2021;96:404-417.
    >> Share

  26. LANZKRON S, Smith-Whitley K
    Swaying sickle cell research forward in support of patient reported outcomes.
    Am J Hematol. 2021;96:402-403.
    >> Share

    March 2021
  27. PATNAIK MM, Tefferi A
    Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management".
    Am J Hematol. 2021;96:379-394.
    >> Share

  28. DENTON CC, Shah P, Suriany S, Liu H, et al
    Loss of alpha-globin genes in human subjects is associated with improved nitric oxide-mediated vascular perfusion.
    Am J Hematol. 2021;96:277-281.
    >> Share

  29. MUSALLAM KM, Rivella S, Taher AT
    Management of non-transfusion-dependent beta-thalassemia (NTDT): The next 5 years.
    Am J Hematol. 2021;96:E57-E59.
    >> Share

    February 2021
  30. ZUBICARAY J, Pagliara D, Sevilla J, Eikema DJ, et al
    Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: results from the Severe Aplastic Anemia Working Party of the EBMT.
    Am J Hematol. 2021 Feb 19. doi: 10.1002/ajh.26135.
    >> Share

  31. ROMANA M, Reminy K, Moeckesch B, Charlot K, et al
    Loss of alpha globin genes is associated with improved microvascular function in patients with sickle cell anemia.
    Am J Hematol. 2021 Feb 13. doi: 10.1002/ajh.26126.
    >> Share

  32. AUERBACH M, Henry D, DeLoughery TG
    Intravenous ferric derisomaltose for the treatment of iron deficiency anemia.
    Am J Hematol. 2021 Feb 13. doi: 10.1002/ajh.26124.
    >> Share

  33. KARKOSKA K, Quinn CT, Niss O, Pfeiffer A, et al
    Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia.
    Am J Hematol. 2021 Feb 3. doi: 10.1002/ajh.26120.
    >> Share

  34. LEBENSBURGER JD, Aban I, Hilliard LM, Feig DI, et al
    Hyperuricemia and Abnormal Nocturnal Dipping Impact Glomerular Filtration Rate in Patients with Sickle Cell Anemia.
    Am J Hematol. 2021 Feb 1. doi: 10.1002/ajh.26115.
    >> Share

  35. MUSALLAM KM, Cappellini MD, Viprakasit V, Kattamis A, et al
    Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later.
    Am J Hematol. 2021;96:E54-E56.
    >> Share

  36. SCHMIDT PJ, Fitzgerald K, Butler JS, Fleming MD, et al
    Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
    Am J Hematol. 2021;96:251-257.
    >> Share

    January 2021
  37. LUNATI A, Petit A, Lapillonne H, Gameiro C, et al
    VPS4A mutation in syndromic congenital hemolytic anemia without obvious signs of dyserythropoiesis.
    Am J Hematol. 2021 Jan 18. doi: 10.1002/ajh.26099.
    >> Share

  38. GLADWIN MT, Kato GJ, Gordeuk VR
    Identifying adolescent and young adult patients with sickle cell disease at highest risk of death.
    Am J Hematol. 2021;96:9-11.
    >> Share

  39. RAB MAE, Kanne CK, Bos J, van Oirschot BA, et al
    Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.
    Am J Hematol. 2021;96:E29-E32.
    >> Share

  40. ROSANWO TO, Kean LS, Archer NM
    End the pain: Start with antiracism.
    Am J Hematol. 2021;96:4-6.
    >> Share

  41. OGU UO, Thomas M, Chan F, Vattappally L, et al
    L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality.
    Am J Hematol. 2021;96:E38-E40.
    >> Share

  42. CHALACHEVA P, Ji Y, Rosen CL, DeBaun MR, et al
    Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease.
    Am J Hematol. 2021;96:60-68.
    >> Share

  43. COSTA E, Tibalinda P, Sterzi E, Leufkens HMG, et al
    Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.
    Am J Hematol. 2021;96:E2-E5.
    >> Share

  44. SHAH P, Suriany S, Kato R, Bush AM, et al
    Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additi
    Am J Hematol. 2021;96:31-39.
    >> Share

    December 2020
  45. KARKOSKA K, Quinn CT, Clapp K, McGann PT, et al
    Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease.
    Am J Hematol. 2020;95:E338-E339.
    >> Share

  46. COHEN J, Khudanyan A, Lu J, Wing J, et al
    A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency.
    Am J Hematol. 2020;95:1572-1577.
    >> Share

    November 2020
  47. DAVIS BH
    Assay for "fetal hemoglobin levels" in erythrocytes: Impact of new In Vitro Diagnostics regulation and expanded applications in sickle cell disease management.
    Am J Hematol. 2020;95:1230-1232.
    >> Share

    Can any new thalassemia therapy achieve a better than 97.4% cure rate?
    Am J Hematol. 2020;95:1233-1234.
    >> Share

  49. HE Y, Jiang H, Li C, Zhu Y, et al
    Long-term results of the NF-08-TM protocol in stem cell transplant for patients with thalassemia major: A multi-center large-sample study.
    Am J Hematol. 2020;95:E297-E299.
    >> Share

  50. RUSSO R, Marra R, Andolfo I, Manna F, et al
    Uridine treatment normalizes the congenital dyserythropoietic anemia type II-like hematological phenotype in a patient with homozygous mutation in the CAD gene.
    Am J Hematol. 2020;95:1423-1426.
    >> Share

  51. MERLET AN, Feasson L, Bartolucci P, Hourde C, et al
    Muscle structural, energetic and functional benefits of endurance exercise training in sickle cell disease.
    Am J Hematol. 2020;95:1257-1268.
    >> Share

  52. HEBERT N, Rakotoson MG, Bodivit G, Audureau E, et al
    Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Am J Hematol. 2020;95:1235-1245.
    >> Share

  53. KUCUKAL E, Man Y, Hill A, Liu S, et al
    Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.
    Am J Hematol. 2020;95:1246-1256.
    >> Share

  54. DE CASTRO C, Grossi F, Weitz IC, Maciejewski J, et al
    C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab.
    Am J Hematol. 2020;95:1334-1343.
    >> Share

    October 2020
  55. POLLYEA DA, Pratz K, Letai A, Jonas BA, et al
    Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow-up from a Phase 1b study.
    Am J Hematol. 2020 Oct 29. doi: 10.1002/ajh.26039.
    >> Share

  56. ONALO R, Cooper P, Cilliers A, Vorster BC, et al
    Randomized Control Trial of Oral Arginine Therapy for Children with Sickle Cell Anemia Hospitalized for Pain in Nigeria.
    Am J Hematol. 2020 Oct 19. doi: 10.1002/ajh.26028.
    >> Share

  57. WOLF M, Auerbach M, Kalra PA, Glaspy J, et al
    Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.
    Am J Hematol. 2020 Oct 7. doi: 10.1002/ajh.26015.
    >> Share

    September 2020
  58. DEBEER T, Jordan LC, Lee CA, Patel NJ, et al
    Evidence of transfusion-induced reductions in cerebral capillary shunting in sickle cell disease.
    Am J Hematol. 2020;95:E228-E230.
    >> Share

  59. SONI S
    Gene therapies for transfusion dependent beta-thalassemia: Current status and critical criteria for success.
    Am J Hematol. 2020;95:1099-1112.
    >> Share

  60. GALADANCI NA, Abdullahi SU, Ali Abubakar S, Wudil Jibir B, et al
    Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
    Am J Hematol. 2020;95:E247-E250.
    >> Share

  61. GEORGE A, Dinu B, Estrada N, Minard CG, et al
    Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
    Am J Hematol. 2020;95:E242-E244.
    >> Share

  62. KNISELY MR, Pugh N, Kroner B, Masese R, et al
    Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
    Am J Hematol. 2020;95:1066-1074.
    >> Share

  63. TISDALE JF, Pierciey FJ Jr, Bonner M, Thompson AA, et al
    Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
    Am J Hematol. 2020;95:E239-E242.
    >> Share

  64. SCARAMELLINI N, Consonni D, Cassinerio E, Arighi C, et al
    A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 mug/L.
    Am J Hematol. 2020;95:E230-E232.
    >> Share

  65. SIDANA S, Murray DL, Dasari S, Go RS, et al
    Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
    Am J Hematol. 2020;95:E222-E225.
    >> Share

  66. TSEU B, Siow W, Pushkaran B, Cheesebrough B, et al
    Beta thalassemia major and Noonan syndrome - Two genetic disorders manifest in the blood film.
    Am J Hematol. 2020;95:1113-1114.
    >> Share

    August 2020
  67. WILDING C, Pelling D, Lund K, Bain BJ, et al
    Erythrophagocytosis by monocytes - an unusual observation in autoimmune hemolytic anemia.
    Am J Hematol. 2020 Aug 18. doi: 10.1002/ajh.25966.
    >> Share

  68. JORDAN LC, Rodeghier M, Donahue MJ, DeBaun MR, et al
    Reduction in TCD velocity after regular blood transfusion therapy is associated with a change in hemoglobin S fraction in sickle cell anemia.
    Am J Hematol. 2020 Aug 10. doi: 10.1002/ajh.25954.
    >> Share

  69. NAYMAGON L, Berwick S, Kessler A, Lancman G, et al
    The emergence of methemoglobinemia amidst the COVID-19 pandemic.
    Am J Hematol. 2020;95:E196-E197.
    >> Share

  70. TAHER AT, Bou-Fakhredin R, Kreidieh F, Motta I, et al
    Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
    Am J Hematol. 2020;95:E208-E210.
    >> Share

  71. KUIPERS MT, van Zwieten R, Heijmans J, Rutten CE, et al
    Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
    Am J Hematol. 2020;95:E194-E196.
    >> Share

  72. ODIEVRE MH, de Marcellus C, Ducou Le Pointe H, Allali S, et al
    Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome.
    Am J Hematol. 2020;95:E192-E194.
    >> Share

  73. MOTTA I, Migone De Amicis M, Pinto VM, Balocco M, et al
    SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.
    Am J Hematol. 2020;95:E198-E199.
    >> Share

  74. MITRA A, Dwyre DM, Schivo M, Thompson GR 3rd, et al
    Leukoerythroblastic reaction in a patient with COVID-19 infection.
    Am J Hematol. 2020;95:999-1000.
    >> Share

  75. MACRAE FL, Peacock-Young B, Bowman P, Baker SR, et al
    Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab.
    Am J Hematol. 2020;95:944-952.
    >> Share

  76. HARPER K, McIlwaine L, Leach M, Bain BJ, et al
    Giant proerythroblasts in pure red cell aplasia due to parvovirus B19 infection in a patient with rheumatoid arthritis.
    Am J Hematol. 2020;95:990-991.
    >> Share

    July 2020
  77. DOMINGUES-HAMDI E, Vasseur C, Pakdaman S, Moutereau S, et al
    Hydroxycarbamide decreases the free alpha-hemoglobin pool in red blood cells of adult patients with sickle cell anemia.
    Am J Hematol. 2020 Jul 28. doi: 10.1002/ajh.25947.
    >> Share

  78. GORDEUK VR, Shah BN, Zhang X, Thuma PE, et al
    CYB5R3(c) (.350C>G) and G6PD A Alleles Modify Severity of Anemia in Malaria and Sickle Cell Disease.
    Am J Hematol. 2020 Jul 22. doi: 10.1002/ajh.25941.
    >> Share

  79. SONG AB, Kuter DJ, Al-Samkari H
    Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia.
    Am J Hematol. 2020 Jul 3. doi: 10.1002/ajh.25925.
    >> Share

  80. DE LUNA G, Habibi A, Deux JF, Colard M, et al
    Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
    Am J Hematol. 2020;95:876-878.
    >> Share

  81. FAN BE, Ong KH, Chan SSW, Young BE, et al
    Blood and blood product use during COVID-19 infection.
    Am J Hematol. 2020;95:E158-E160.
    >> Share

  82. BEERKENS F, John M, Puliafito B, Corbett V, et al
    COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.
    Am J Hematol. 2020;95:E154-E156.
    >> Share

  83. NOURAIE M, Darbari DS, Rana S, Minniti CP, et al
    Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.
    Am J Hematol. 2020;95:766-774.
    >> Share

  84. VAN TUIJN CFJ, Gaartman AE, Nur E, Rijneveld AW, et al
    Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial.
    Am J Hematol. 2020;95:E160-E163.
    >> Share

    June 2020
  85. ACHEBE MM, Glaspy J, Kalra PA, Auerbach M, et al
    A six month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial.
    Am J Hematol. 2020 Jun 29. doi: 10.1002/ajh.25920.
    >> Share

  86. NUR E, Gaartman AE, van Tuijn CFJ, Tang MW, et al
    Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).
    Am J Hematol. 2020;95:725-726.
    >> Share

  87. LIM SH, Dutta D
    Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease.
    Am J Hematol. 2020;95:E151-E153.
    >> Share

  88. HAUGHTON A, Stylian S, Bain BJ
    Stress erythropoiesis in hereditary spherocytosis.
    Am J Hematol. 2020;95:710-711.
    >> Share

    May 2020
  89. LOFARO T, Bain BJ
    Schistocytosis is not always microangiopathic hemolytic anemia.
    Am J Hematol. 2020 May 10. doi: 10.1002/ajh.25861.
    >> Share

  90. BIANCHI P, Fermo E, Lezon-Geyda K, van Beers EJ, et al
    Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.
    Am J Hematol. 2020;95:472-482.
    >> Share

  91. SCHMIDT PJ, Hollowell ML, Fitzgerald K, Butler JS, et al
    Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
    Am J Hematol. 2020;95:492-496.
    >> Share

  92. ROUMENINA LT, Chadebech P, Bodivit G, Vieira-Martins P, et al
    Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.
    Am J Hematol. 2020;95:456-464.
    >> Share

    Now I Am The Voice: "a journey of self-discovery through the eyes of a Thalassemic".
    Am J Hematol. 2020;95:E105-E107.
    >> Share

    April 2020
  94. PROCHASKA MT, Zhang H, Alavi C, Meltzer DO, et al
    Fatigability: A new perspective on and patient-centered outcome measure for patients with anemia.
    Am J Hematol. 2020 Apr 15. doi: 10.1002/ajh.25803.
    >> Share

  95. GIARDINO S, Peffault de Latour R, Aljurf M, Eikema DJ, et al
    Outcome of Patients with Fanconi Anemia developing myelodysplasia and acute leukemia who received Allogeneic Hematopoietic Stem Cell Transplantation: A retrospective analysis on Behalf of EBMT group.
    Am J Hematol. 2020 Apr 8. doi: 10.1002/ajh.25810.
    >> Share

  96. HWANG SR, O'Dowd T, Markovic SN, Wolanskyj-Spinner AP, et al
    Recurrent Checkpoint Inhibitor-Induced Warm Agglutinin Autoimmune Hemolytic Anemia in a Patient with Metastatic Melanoma.
    Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25812.
    >> Share

  97. AL-BUBSEREE B, Leach M, Jones R, Bain BJ, et al
    The hematological effects of copper deficiency.
    Am J Hematol. 2020;95:446.
    >> Share

  98. ESPINOZA J, Shah P, Veluswamy S, Zeltzer L, et al
    Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile application.
    Am J Hematol. 2020;95:E101-E103.
    >> Share

  99. DUTTA D, Li K, Methe B, Lim SH, et al
    Rifaximin on intestinally-related pathologic changes in sickle cell disease.
    Am J Hematol. 2020;95:E83-E86.
    >> Share

  100. VACLAVU L, Petr J, Petersen ET, Mutsaerts HJMM, et al
    Cerebral oxygen metabolism in adults with sickle cell disease.
    Am J Hematol. 2020;95:401-412.
    >> Share

  101. GONDELAUD F, Connes P, Nader E, Renoux C, et al
    Sialic acids rather than glycosaminoglycans affect normal and sickle red blood cell rheology by binding to four major sites on fibrinogen.
    Am J Hematol. 2020;95:E77-E80.
    >> Share

    March 2020
  102. MANARA R, Canna A, Caiazza M, Ponticorvo S, et al
    White matter volume changes in adult beta-thalassemia: negligible and unrelated to anemia and cognitive performances.
    Am J Hematol. 2020 Mar 20. doi: 10.1002/ajh.25790.
    >> Share

  103. CHOI S, Leahy RM, Wood JC
    Lower White Matter Volume in Beta-Thalassemia Associated with Anemia and Cognitive Performance.
    Am J Hematol. 2020 Mar 17. doi: 10.1002/ajh.25787.
    >> Share

  104. IKWUANUSI I, Jordan LC, Lee CA, Patel NJ, et al
    Cerebral hemodynamics and metabolism are similar in sickle cell disease patients with hemoglobin SS and Sbeta(0) thalassemia phenotypes.
    Am J Hematol. 2020;95:E66-E68.
    >> Share

  105. FOY BH, Li A, McClung JP, Ranganath R, et al
    Data-driven physiologic thresholds for iron deficiency associated with hematologic decline.
    Am J Hematol. 2020;95:302-309.
    >> Share

  106. ZHANG X, Shah BN, Zhang W, Saraf SL, et al
    S100B has pleiotropic effects on vaso-occlusive manifestations in sickle cell disease.
    Am J Hematol. 2020;95:E62-E65.
    >> Share

    February 2020
  107. SARNA K, Brittenham GM, Beall CM
    Current WHO hemoglobin thresholds for altitude and misdiagnosis of anemia among Tibetan highlanders.
    Am J Hematol. 2020 Feb 25. doi: 10.1002/ajh.25765.
    >> Share

  108. BELISARIO AR, de Almeida JA, Mendes FG, da Silva DMM, et al
    Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia.
    Am J Hematol. 2020 Feb 21. doi: 10.1002/ajh.25763.
    >> Share

  109. TOLU S, Reyes-Gil M, Ogu UO, Thomas M, et al
    Inherited High Fetal Hemoglobin in Sickle Cell Anemia: Outcomes with Aging High HbF and Sickle Cell.
    Am J Hematol. 2020 Feb 18. doi: 10.1002/ajh.25759.
    >> Share

  110. SCHECKEL CJ, Yanardag Acik D, Ravindran A, Marshall A, et al
    Hapticophagia: Tactile chew cravings in iron deficiency anemia.
    Am J Hematol. 2020 Feb 5. doi: 10.1002/ajh.25749.
    >> Share

  111. EATON WA
    Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling's Science paper.
    Am J Hematol. 2020;95:205-211.
    >> Share

  112. ANDOLFO I, Rosato BE, Manna F, De Rosa G, et al
    Gain-of-function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway.
    Am J Hematol. 2020;95:188-197.
    >> Share

  113. GENDREAU S, Scholer M, Cecchini J, Habibi A, et al
    Cerebral fat embolism in sickle cell disease.
    Am J Hematol. 2020;95:E41-E45.
    >> Share

    January 2020
  114. WALSH K, Blalock DV, Mehler PS
    Hematologic Findings in a Large Sample of Patients with Anorexia Nervosa and Bulimia Nervosa.
    Am J Hematol. 2020 Jan 15. doi: 10.1002/ajh.25732.
    >> Share

    Treating Sickle Cell Anemia: A New Era Dawns.
    Am J Hematol. 2020 Jan 10. doi: 10.1002/ajh.25724.
    >> Share

  116. WILLEN SM, McNeil JB, Rodeghier M, Kerchberger VE, et al
    Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia.
    Am J Hematol. 2020 Jan 9. doi: 10.1002/ajh.25728.
    >> Share

  117. QASRAWI A, Arora R, Ramlal R, Munker R, et al
    Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
    Am J Hematol. 2020 Jan 9. doi: 10.1002/ajh.25725.
    >> Share

  118. RICHARD F, van Lier JJ, Roubert B, Haboubi T, et al
    Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers.
    Am J Hematol. 2020;95:68-77.
    >> Share

  119. RAB MAE, Kanne CK, Bos J, Boisson C, et al
    Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.
    Am J Hematol. 2020;95:E5-E8.
    >> Share

  120. SCHYRR F, Dolci M, Nydegger M, Canellini G, et al
    Perioperative care of children with sickle cell disease: A systematic review and clinical recommendations.
    Am J Hematol. 2020;95:78-96.
    >> Share

  121. BAIN BJ
    Delta beta thalassemia.
    Am J Hematol. 2020;95:116.
    >> Share

    December 2019
  122. TRUDEL G, Shafer J, Laneuville O, Ramsay T, et al
    Characterizing the effect of exposure to microgravity on anemia, more space is worse.
    Am J Hematol. 2019 Dec 9. doi: 10.1002/ajh.25699.
    >> Share

  123. KAKO S, Kanda Y, Onizuka M, Aotsuka N, et al
    Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: a KSGCT prospective study.
    Am J Hematol. 2019 Dec 5. doi: 10.1002/ajh.25693.
    >> Share

  124. NEUBERG D
    Dissecting the web of ischemic stroke, sickle cell trait, and chronic kidney disease.
    Am J Hematol. 2019;94:1302.
    >> Share

    November 2019
  125. ATAGA KI, Wichlan D, Elsherif L, Derebail VK, et al
    A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.
    Am J Hematol. 2019;94:E299-E301.
    >> Share

  126. ANDOLFO I, Rosato BE, Marra R, De Rosa G, et al
    The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant.
    Am J Hematol. 2019;94:1227-1235.
    >> Share

  127. HALKES C, de Wreede LC, Knol C, Simand C, et al
    Allogeneic stem cell transplantation for acquired pure red cell aplasia.
    Am J Hematol. 2019;94:E294-E296.
    >> Share

    September 2019
  128. KARKI NR, Auerbach M
    Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron.
    Am J Hematol. 2019;94:E229-E231.
    >> Share

    August 2019
  129. GALADANCI AA, Galadanci NA, Jibir BW, Abdullahi SU, et al
    Approximately 40,000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Am J Hematol. 2019 Aug 18. doi: 10.1002/ajh.25616.
    >> Share

  130. PATEL R, Kang S, Valeshabad AK, Shah BN, et al
    Kidney Ultrasound Findings According to Kidney Function in Sickle Cell Anemia.
    Am J Hematol. 2019 Aug 4. doi: 10.1002/ajh.25602.
    >> Share

  131. BATHINI S, Holtzman NG, Koka R, Singh Z, et al
    Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
    Am J Hematol. 2019;94:E216-E219.
    >> Share

  132. TAHER AT, Cappellini MD, Musallam KM
    Development of a thalassemia-related thrombosis risk scoring system.
    Am J Hematol. 2019;94:E207-E209.
    >> Share

    July 2019
  133. KAWATA E, Chin-Yee I, Hsia C, Solh Z, et al
    IgA-mediated autoimmune hemolytic anemia.
    Am J Hematol. 2019 Jul 21. doi: 10.1002/ajh.25581.
    >> Share

  134. SOYOUNG CHOI BA, O'Neil SH, Joshi AA, Li J, et al
    Anemia Predicts Lower White Matter Volume and Cognitive Performance in Sickle and Non-Sickle Cell Anemia Syndrome.
    Am J Hematol. 2019 Jul 1. doi: 10.1002/ajh.25570.
    >> Share

    June 2019
  135. AUERBACH M, Henry D, Derman RJ, Achebe MM, et al
    A prospective, multicenter, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia (the FERWON-IDA trial).
    Am J Hematol. 2019 Jun 26. doi: 10.1002/ajh.25564.
    >> Share

  136. FATTIZZO B, Cavallaro F, Milesi G, Barcellini W, et al
    Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.
    Am J Hematol. 2019 Jun 6. doi: 10.1002/ajh.25550.
    >> Share

  137. DETTERICH JA, Kato R, Bush A, Chalacheva P, et al
    Sickle cell microvascular paradox-oxygen supply-demand mismatch.
    Am J Hematol. 2019;94:678-688.
    >> Share

  138. DUTTA D, Methe BA, Morris A, Lim SH, et al
    Effects of rifaximin on circulating aged neutrophils in sickle cell disease.
    Am J Hematol. 2019;94:E175-E176.
    >> Share

  139. NANKANJA R, Kadhumbula S, Tagoola A, Geisberg M, et al
    HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda.
    Am J Hematol. 2019;94:E164-E166.
    >> Share

  140. DUTTA D, Methe B, Morris A, Lim SH, et al
    Elevated urinary 3-indoxyl sulfate in sickle cell disease.
    Am J Hematol. 2019;94:E162-E164.
    >> Share

  141. ITZEP NP, Jadhav SP, Kanne CK, Sheehan VA, et al
    Spontaneous healing of avascular necrosis of the femoral head in sickle cell disease.
    Am J Hematol. 2019;94:E160-E162.
    >> Share

    May 2019
  142. MCGANN PT, Niss O, Dong M, Marahatta A, et al
    Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children with Sickle Cell Anemia.
    Am J Hematol. 2019 May 20. doi: 10.1002/ajh.25510.
    >> Share

  143. BRUNSON A, Keegan T, Mahajan A, White R, et al
    High Incidence of Venous Thromboembolism Recurrence in Patients with Sickle Cell Disease.
    Am J Hematol. 2019 May 9. doi: 10.1002/ajh.25508.
    >> Share

  144. RAJAGOPAL R, Bennett R, Liang J, Royle G, et al
    High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre.
    Am J Hematol. 2019 May 7. doi: 10.1002/ajh.25504.
    >> Share

  145. RAB MAE, van Oirschot BA, Bos J, Merkx TH, et al
    Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Am J Hematol. 2019;94:575-584.
    >> Share

  146. VINER M, Zhou J, Allison D, Han J, et al
    The morbidity and mortality of end stage renal disease in sickle cell disease.
    Am J Hematol. 2019;94:E138-E141.
    >> Share

  147. WALKER AL, Gaydos LM, Farzan R, De Castro L, et al
    Social media discussions provide new insight about perceptions of hydroxyurea in the sickle cell community.
    Am J Hematol. 2019;94:E134-E136.
    >> Share

  148. WEISS M, Parisi Jun M, Sheth S
    Clinical and economic burden of regularly transfused adult patients with beta-thalassemia in the United States: A retrospective cohort study using payer claims.
    Am J Hematol. 2019;94:E129-E132.
    >> Share

    Erythrocyte ATP, a possible therapeutic approach for sickle cell disease.
    Am J Hematol. 2019;94:E117.
    >> Share

  150. BAO EL, Lareau CA, Brugnara C, Fulcher IR, et al
    Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
    Am J Hematol. 2019;94:522-527.
    >> Share

    April 2019
  151. CHAI Y, Bush AM, Coloigner J, Nederveen AJ, et al
    White matter has impaired resting oxygen delivery in sickle cell patients.
    Am J Hematol. 2019;94:467-474.
    >> Share

  152. KIM TO, Grimes AB, Kirk S, Arulselvan A, et al
    Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.
    Am J Hematol. 2019;94:461-466.
    >> Share

  153. TAHER AT, Origa R, Perrotta S, Kouraklis A, et al
    Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
    Am J Hematol. 2019;94:E96-E99.
    >> Share

  154. OYEDEJI C, Strouse JJ, Crawford RD, Garrett ME, et al
    A multi-institutional comparison of younger and older adults with sickle cell disease.
    Am J Hematol. 2019;94:E115-E117.
    >> Share

  155. LEBENSBURGER JD, Aban I, Pernell B, Kasztan M, et al
    Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
    Am J Hematol. 2019;94:417-423.
    >> Share

  156. ALLY M, Magesa P, Luzzatto L
    High frequency of acquired aplastic anemia in Tanzania.
    Am J Hematol. 2019;94:E86-E88.
    >> Share

  157. REES C, Lund K, Bain BJ
    Infantile pyknocytosis.
    Am J Hematol. 2019;94:489-490.
    >> Share

    March 2019
  158. CARDEN MA, Brousseau DC, Ahmad FA, Bennett J, et al
    Normal Saline Bolus Use in Pediatric Emergency Departments is Associated with Worse Pain Control in Children with Sickle Cell Anemia and Vaso-occlusive Pain.
    Am J Hematol. 2019 Mar 27. doi: 10.1002/ajh.25471.
    >> Share

  159. JORDAN LC, Juttukonda MR, Kassim AA, DeBaun MR, et al
    Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease.
    Am J Hematol. 2019 Mar 5. doi: 10.1002/ajh.25455.
    >> Share

  160. VERCELLOTTI GM, Dalmasso AP, Schaid TR Jr, Nguyen J, et al
    Critical role of C5a in sickle cell disease.
    Am J Hematol. 2019;94:327-337.
    >> Share

  161. CASALE M, Filosa A, Ragozzino A, Amendola G, et al
    Long-term improvement in cardiac magnetic resonance in beta-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
    Am J Hematol. 2019;94:312-318.
    >> Share

  162. RODGERS GM, Kurtti AL, Gilreath JA
    Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.
    Am J Hematol. 2019;94:394-395.
    >> Share

    February 2019
  163. LEAF RK, Ferreri C, Rangachari D, Mier J, et al
    Clinical and Laboratory Features of Autoimmune Hemolytic Anemia Associated with Immune Checkpoint Inhibitors.
    Am J Hematol. 2019 Feb 20. doi: 10.1002/ajh.25448.
    >> Share

  164. STEWART JT, Willen SM, Cohen R, Rodeghier M, et al
    BMI percentile is an independent predictor of increase in lung function in children with sickle cell anemia.
    Am J Hematol. 2019 Feb 7. doi: 10.1002/ajh.25433.
    >> Share

  165. MARSHALL AL, Mann S, Wolanskyj-Spinner A
    Digital storytelling for hematology education: Interactive thalassemia module for graduate millennial learners.
    Am J Hematol. 2019;94:E66-E67.
    >> Share

  166. DESAI PC, Kendel N, Huang Y, Heinlein M, et al
    Hypoxia in sickle cell disease due to right to left shunting.
    Am J Hematol. 2019;94:E53-E55.
    >> Share

  167. OPPONG SA, Asare EV, Olayemi E, Boafor T, et al
    Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.
    Am J Hematol. 2019;94:223-230.
    >> Share

  168. GURUPRASAD P, Mannino RG, Caruso C, Zhang H, et al
    Integrated automated particle tracking microfluidic enables high-throughput cell deformability cytometry for red cell disorders.
    Am J Hematol. 2019;94:189-199.
    >> Share

  169. EISENGA MF, Wouters HJCM, Kieneker LM, van der Klauw MM, et al
    Active smoking and macrocytosis in the general population: Two population-based cohort studies.
    Am J Hematol. 2019;94:E45-E48.
    >> Share

  170. TAHER A, Viprakasit V, Cappellini MD, Sutcharitchan P, et al
    Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:171-176.
    >> Share

  171. SHARARA AI, Rustom LBO, Marrache M, Rimmani HH, et al
    Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.
    Am J Hematol. 2019;94:E43-E45.
    >> Share

  172. TAHER A, Cappellini MD, Viprakasit V, Sutcharitchan P, et al
    Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO((c)) ).
    Am J Hematol. 2019;94:177-183.
    >> Share

    January 2019
  173. JIE Z, Jie M, Run-Hui W, Xue Z, et al
    Unusual presentations of sitosterolemia limited to hematological abnormalities: A report of 4 cases presenting with stomatocytic anemia and thrombocytopenia with macrothrombocytes.
    Am J Hematol. 2019 Jan 29. doi: 10.1002/ajh.25427.
    >> Share

  174. AKINGBOLA TS, Tayo BO, Ezekekwu CA, Sonubi O, et al
    "Maximum Tolerated Dose" versus "Fixed Low-Dose" Hydroxyurea for Treatment of Adults with Sickle Cell Anemia.
    Am J Hematol. 2019 Jan 21. doi: 10.1002/ajh.25412.
    >> Share

  175. OZCAN A, Saracoglu S, Verboon J, Karakukcu M, et al
    A mummy emerges from the grave: Scurvy confounding the clinical presentation of a child with Fanconi Anemia.
    Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25402.
    >> Share

  176. KRISHNAMURTI L, Neuberg DS, Sullivan KM, Kamani NR, et al
    Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study.
    Am J Hematol. 2019 Jan 13. doi: 10.1002/ajh.25401.
    >> Share

  177. PATNAIK MM, Tefferi A
    Refractory Anemia with Ring Sideroblasts (RARS) and RARS with Thrombocytosis (RARS-T) - "2019 Update on Diagnosis, Risk-stratification, and Management".
    Am J Hematol. 2019 Jan 7. doi: 10.1002/ajh.25397.
    >> Share

  178. BACIGALUPO A, Oneto R, Schrezenmeier H, Hochsmann B, et al
    First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012.
    Am J Hematol. 2019;94:165.
    >> Share

  179. BIANCHI P, Fermo E, Glader B, Kanno H, et al
    Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
    Am J Hematol. 2019;94:149-161.
    >> Share

  180. HAN J, Saraf SL, Molokie RE, Gordeuk VR, et al
    Use of metformin in patients with sickle cell disease.
    Am J Hematol. 2019;94:E13-E15.
    >> Share

  181. HAN J, Saraf SL, Gowhari M, Jain S, et al
    High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.
    Am J Hematol. 2019;94:E5-E7.
    >> Share

  182. CHAPMAN MS, Kiritkumar K, Lund K, Bain BJ, et al
    An unusual hemoglobinopathy: compound heterozygosity for hemoglobins C and E.
    Am J Hematol. 2019;94:144.
    >> Share

  183. KUTLAR A, Kanter J, Liles DK, Alvarez OA, et al
    Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis.
    Am J Hematol. 2019;94:55-61.
    >> Share

  184. STEELE C, Sinski A, Asibey J, Hardy-Dessources MD, et al
    Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Am J Hematol. 2019;94:39-45.
    >> Share

    December 2018
  185. SHET AS, Mendelsohn L, Harper J, Ostrowski D, et al
    Voxelotor Treatment of a Patient With Sickle Cell Disease and Very Severe Anemia.
    Am J Hematol. 2018 Dec 27. doi: 10.1002/ajh.25389.
    >> Share

  186. ARIGLIANI M, Dogara LG, Zubair R, Castriotta L, et al
    Lung function impairment in pediatric patients with sickle cell anemia from Nigeria is associated with low steady state hemoglobin.
    Am J Hematol. 2018 Dec 8. doi: 10.1002/ajh.25373.
    >> Share

    November 2018
  187. WANG CY, Canali S, Bayer A, Dev S, et al
    Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2-deficient mice, but serum iron fails to induce hepcidin in Bmp6-deficient mice.
    Am J Hematol. 2018 Nov 27. doi: 10.1002/ajh.25366.
    >> Share

  188. CHATURVEDI S, Koo M, Dackiw L, Koo G, et al
    Preoperative Treatment of Anemia and Outcomes in Surgical Jehovah's Witness Patients.
    Am J Hematol. 2018 Nov 25. doi: 10.1002/ajh.25359.
    >> Share

    October 2018
  189. LEE JW, Peffault de Latour R, Brodsky RA, Jang JH, et al
    Effectiveness of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With or Without Aplastic Anemia in the International PNH Registry.
    Am J Hematol. 2018 Oct 29. doi: 10.1002/ajh.25334.
    >> Share

  190. ZAHR RS, Hankins JS, Kang G, Li C, et al
    Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
    Am J Hematol. 2018 Oct 25. doi: 10.1002/ajh.25329.
    >> Share

  191. AUSTIN A, Lund K, Bain BJ
    Striking dyserythropoiesis in sickle cell anemia following an aplastic crisis.
    Am J Hematol. 2018 Oct 25. doi: 10.1002/ajh.25324.
    >> Share

  192. SAMARASINGHE S, Clesham K, Iacobelli S, Sbianchi G, et al
    Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25314.
    >> Share

  193. PRYCE A, Lund K, Shah M, Bain BJ, et al
    Pertussis - an uncommon cause of microangiopathic hemolytic anemia in an infant.
    Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25315.
    >> Share

    September 2018
  194. DARBARI DS, Eigbire-Molen O, Ponisio MR, Milchenko MV, et al
    Progressive Loss of Brain Volume in Children with Sickle Cell Anemia and Silent Cerebral Infarct: A Report from the Silent Cerebral Infarct Transfusion (SIT) Trial.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25297.
    >> Share

  195. EGBERG MD, Mitchell PD, Galanko JP, Rufo PA, et al
    Effectiveness of Oral Iron Supplementation in Treatment of Anemia Associated with Pediatric Ulcerative Colitis Flare.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25299.
    >> Share

  196. DI M, Bian J, Butera JN
    A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis.
    Am J Hematol. 2018 Sep 28. doi: 10.1002/ajh.25298.
    >> Share

  197. BENEDUCE E, Matte A, De Falco L, Mbiandjeu S, et al
    Am J Hematol. 2018 Sep 25. doi: 10.1002/ajh.25295.
    >> Share

    August 2018
  198. BROUSSE V, El Hoss S, Bouazza N, Arnaud C, et al
    Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.
    Am J Hematol. 2018 Aug 21. doi: 10.1002/ajh.25260.
    >> Share

  199. LEE SE, Park SS, Jeon YW, Yoon JH, et al
    Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.
    Am J Hematol. 2018 Aug 17. doi: 10.1002/ajh.25257.
    >> Share

  200. VAN STRAATEN S, Biemond BJ, Kerkhoffs JL, Gitz-Francois J, et al
    Iron overload in patients with rare hereditary hemolytic anemia: evidence based suggestion on whom and how to screen.
    Am J Hematol. 2018 Aug 13. doi: 10.1002/ajh.25251.
    >> Share

    July 2018
  201. HANINA S, Bain BJ, Clark B, Layton DM, et al
    Congenital sideroblastic anemia in a female.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25196.
    >> Share

  202. SARNA K, Gebremedin A, Brittenham GM, Beall CM, et al
    WHO hemoglobin thresholds for altitude increase the prevalence of anemia among Ethiopian highlanders.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25194.
    >> Share

  203. SHANDER A, Goodnough LT
    Management of anemia in patients who decline blood transfusion.
    Am J Hematol. 2018 Jul 22. doi: 10.1002/ajh.25167.
    >> Share

  204. STRAUSS WE, Adkinson NF, Macdougall IC, Auerbach M, et al
    A response by Strauss et al. to "A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".
    Am J Hematol. 2018 Jul 17. doi: 10.1002/ajh.25200.
    >> Share

  205. BARCELLINI W, Zaninoni A, Fattizzo B, Giannotta JA, et al
    Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from 8 Italian Reference Centers.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25212.
    >> Share

  206. MUNDY LM, Wohlfeil S
    A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25204.
    >> Share

    June 2018
  207. PALMBLAD J, Sander B, Bain B, Klimkowska M, et al
    Congenital dyserythropoietic anemia type 1: a case with novel compound heterozygous mutations in the C15orf41 gene.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25157.
    >> Share

  208. GANSNER JM, Furutani E, Campagna DR, Fleming MD, et al
    Pancreatic lipomatosis in Diamond-Blackfan anemia: The importance of genetic testing in bone marrow failure disorders.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25155.
    >> Share

    May 2018
  209. TAYO BO, Akingbola TS, Saraf SL, Shah BN, et al
    Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria.
    Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25143.
    >> Share

    April 2018
  210. ROY S, Rai P, Eiymo Mwa Mpollo MS, Chang KH, et al
    Angiotensin Receptor Signaling in Sickle Cell Anemia has a Reno-Protective effect on Urine Concentrating Ability but results in Sickle Glomerulopathy.
    Am J Hematol. 2018 Apr 20. doi: 10.1002/ajh.25118.
    >> Share

  211. PENNA D, Nicolosi M, Vallapureddy RR, Szuber N, et al
    The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.
    Am J Hematol. 2018 Apr 16. doi: 10.1002/ajh.25114.
    >> Share

    March 2018
  212. PERGOLA PE, Fishbane S, LeWinter RD, Neylan JF, et al
    Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.
    Am J Hematol. 2018 Mar 25. doi: 10.1002/ajh.25088.
    >> Share

  213. DERMAN R, Roman E, Smith-Nguyen GN, Achebe MM, et al
    Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
    Am J Hematol. 2018 Mar 23. doi: 10.1002/ajh.25094.
    >> Share

  214. JORDAN LC, Williams DOR, Rodeghier MJ, Covert B, et al
    Children with sickle cell anemia with normal TCD and without silent infarcts have a low incidence of new strokes.
    Am J Hematol. 2018 Mar 9. doi: 10.1002/ajh.25085.
    >> Share

  215. BACIGALUPO A, Oneto R, Schrezenmeier H, Hochsmann B, et al
    First line treatment of aplastic anemia with thymoglobuline in europe and asia: Outcome of 955 patients treated 2001-2012.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25081.
    >> Share

  216. SCHMIDT PJ, Liu K, Visner G, Fitzgerald K, et al
    RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of beta-thalassemia intermedia.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25079.
    >> Share

  217. GALADANCI NA, Umar Abdullahi S, Vance LD, Musa Tabari A, et al
    Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Am J Hematol. 2018;93:E83.
    >> Share

    February 2018
  218. ADKINSON NF, Strauss WE, Macdougall IC, Bernard KE, et al
    Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.
    Am J Hematol. 2018 Feb 8. doi: 10.1002/ajh.25060.
    >> Share

  219. ASSI R, Kantarjian HM, Garcia-Manero G, Cortes JE, et al
    A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
    Am J Hematol. 2018;93:277-285.
    >> Share

  220. JEREBTSOVA M, Saraf SL, Lin X, Lee G, et al
    Identification of ceruloplasmin as a biomarker of chronic kidney disease in urine of sickle cell disease patients by proteomic analysis.
    Am J Hematol. 2018;93:E45-E47.
    >> Share

  221. ELALFY MS, Adly A, Awad H, Tarif Salam M, et al
    Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial.
    Am J Hematol. 2018;93:262-268.
    >> Share

  222. KHAN AB, Kesse-Adu R, Breen C, Murphy PB, et al
    A descriptive study of the characteristics of older adults with sickle cell disease.
    Am J Hematol. 2018;93:E38-E40.
    >> Share

  223. TANABE P, Silva S, Bosworth HB, Crawford R, et al
    A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Am J Hematol. 2018;93:159-168.
    >> Share

    January 2018
  224. PEFFAULT DE LATOUR R, Tabrizi R, Marcais A, Leblanc T, et al
    Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia.
    Am J Hematol. 2018 Jan 27. doi: 10.1002/ajh.25050.
    >> Share

  225. HERGOTT CB, Pozdnyakova O
    Evans syndrome secondary to undiagnosed chronic lymphocytic leukemia in a patient with unexplained bleeding.
    Am J Hematol. 2018 Jan 17. doi: 10.1002/ajh.25039.
    >> Share

  226. JEREBTSOVA M, Saraf SL, Soni S, Afangbedji N, et al
    Urinary Orosomucoid is Associated with Progressive Chronic Kidney Disease Stage in Patients with Sickle Cell Anemia.
    Am J Hematol. 2018 Jan 12. doi: 10.1002/ajh.25036.
    >> Share

  227. VANHINSBERGH L, Uthaya S, Bain BJ
    Methylene blue-induced Heinz body hemolytic anemia in a premature neonate.
    Am J Hematol. 2018 Jan 5. doi: 10.1002/ajh.25028.
    >> Share

  228. ANDOLFO I, Russo R, Gambale A, Iolascon A, et al
    Hereditary stomatocytosis: An underdiagnosed condition.
    Am J Hematol. 2018;93:107-121.
    >> Share

  229. BARRETT A, Catherwood M, Thornton P, Murphy P, et al
    Transformation of MDS/MPN-RS-T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy.
    Am J Hematol. 2018;93:E16-E17.
    >> Share

  230. NOLAN VG, Anderson SM, Smeltzer MP, Porter JS, et al
    Pediatric to adult care co-location transitional model for youth with sickle cell disease.
    Am J Hematol. 2018;93:E30-E32.
    >> Share

  231. NICOLOSI M, Mudireddy M, Vallapureddy R, Gangat N, et al
    Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Am J Hematol. 2018;93:E27-E30.
    >> Share

  232. HAN J, Saraf SL, Kavoliunaite L, Jain S, et al
    Program expansion of a day hospital dedicated to manage sickle cell pain.
    Am J Hematol. 2018;93:E20-E21.
    >> Share

  233. KAUFMAN HW, Niles JK, Gallagher DR, Rivera A, et al
    Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database.
    Am J Hematol. 2018;93:E9-E12.
    >> Share

  234. GINWALLA M, AlMasoud A, Tofovic D, Alin T, et al
    Cardiovascular evaluation and management of iron overload cardiomyopathy in sickle cell disease.
    Am J Hematol. 2018;93:E7-E9.
    >> Share

    December 2017
  235. FATTIZZO B, Zaninoni A, Gianelli U Prof, Zanella A Prof, et al
    Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia.
    Am J Hematol. 2017 Dec 23. doi: 10.1002/ajh.25020.
    >> Share

  236. WILLEN SM, Rodeghier M, Rosen CL, DeBaun MR, et al
    Sleep disordered breathing does not predict acute severe pain episodes in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 20. doi: 10.1002/ajh.25013.
    >> Share

  237. WILLEN SM, Cohen R, Rodeghier M, Kirkham F, et al
    Age is the only predictor of small decrease in lung function in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 11. doi: 10.1002/ajh.25003.
    >> Share

  238. DAVIES JOJ, Hart AC, De La Fuente J, Bain BJ, et al
    Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia.
    Am J Hematol. 2017 Dec 2. doi: 10.1002/ajh.24995.
    >> Share

  239. DE FALCO L, Tortora R, Imperatore N, Bruno M, et al
    The role of tmprss6 and hfe variants in iron deficiency anemia in celiac disease.
    Am J Hematol. 2017 Dec 1. doi: 10.1002/ajh.24991.
    >> Share

  240. PINTO VM, Gianesin B, Balocco M, Bacigalupo L, et al
    Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients.
    Am J Hematol. 2017;92:E666-E668.
    >> Share

  241. TAHER AT, Saliba AN, Kuo KH, Giardina PJ, et al
    Safety and pharmacokinetics of the oral iron chelator SP-420 in beta-thalassemia.
    Am J Hematol. 2017;92:1356-1361.
    >> Share

  242. NARBEY D, Habibi A, Chadebech P, Mekontso-Dessap A, et al
    Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Am J Hematol. 2017;92:1340-1348.
    >> Share

  243. SALIBA AN, Moukhadder HM, Harb A, Beydoun H, et al
    Causes of hospital admission in beta-thalassemia (CHAT) in Lebanon from 1995 to 2015: A pilot retrospective study from a tertiary care center.
    Am J Hematol. 2017;92:E652-E653.
    >> Share

  244. CAOCCI G, Orofino MG, Vacca A, Piroddi A, et al
    Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
    Am J Hematol. 2017;92:1303-1310.
    >> Share

  245. WORSHAM CM, Martin ST, Nouraie SM, Cohen RT, et al
    Clinical and laboratory findings associated with sleep disordered breathing in sickle cell disease.
    Am J Hematol. 2017;92:E649-E651.
    >> Share

  246. SCHARMAN CD, Burger D, Shatzel JJ, Kim E, et al
    Treatment of individuals who cannot receive blood products for religious or other reasons.
    Am J Hematol. 2017;92:1370-1381.
    >> Share

    November 2017
  247. CASALE M, Borriello A, Scianguetta S, Roberti D, et al
    Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload.
    Am J Hematol. 2017 Nov 27. doi: 10.1002/ajh.24988.
    >> Share

  248. MACHARIA AW, Mochamah G, Uyoga S, Ndila CM, et al
    The clinical epidemiology of sickle cell anemia in Africa.
    Am J Hematol. 2017 Nov 23. doi: 10.1002/ajh.24986.
    >> Share

  249. ALTMAN JK, Foran JM, Pratz KW, Trone D, et al
    Phase 1 Study of Quizartinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
    Am J Hematol. 2017 Nov 15. doi: 10.1002/ajh.24974.
    >> Share

  250. KHALEEL M, Puliyel M, Shah P, Sunwoo J, et al
    Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.
    Am J Hematol. 2017;92:1137-1145.
    >> Share

  251. SOLOVEY A, Somani A, Belcher JD, Milbauer L, et al
    A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
    Am J Hematol. 2017;92:1119-1130.
    >> Share

  252. NADER E, Connes P, Lamarre Y, Renoux C, et al
    Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.
    Am J Hematol. 2017;92:E629-E630.
    >> Share

  253. SCHIMMEL M, Luken BM, Nur E, van Tuijn CFJ, et al
    Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease.
    Am J Hematol. 2017;92:E634-E636.
    >> Share

  254. ORIGA R, Tatti F, Zappu A, Leoni GB, et al
    Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia.
    Am J Hematol. 2017;92:E627-E628.
    >> Share

    October 2017
  255. GONZALES GF, Rubin de Celis V, Begazo J, Hinojosa MDR, et al
    Correcting the cut-off point of hemoglobin at high altitude favors misclassification of anemia, erythrocytosis and excessive erythrocytosis.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24932.
    >> Share

  256. MARTINEZ C, Watson DJ, Shebl A, Wallenhorst C, et al
    Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment - a hospital-based cohort study in the US.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24931.
    >> Share

  257. VAN TUIJN CFJ, Schimmel M, van Beers EJ, Nur E, et al
    Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    Am J Hematol. 2017;92:E584-E590.
    >> Share

  258. SUN CW, Wu LC, Knopick PL, Bradley DS, et al
    Sickle cells produce functional immune modulators and cytotoxics.
    Am J Hematol. 2017;92:981-988.
    >> Share

  259. CAPPELLINI MD, Comin-Colet J, de Francisco A, Dignass A, et al
    Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.
    Am J Hematol. 2017;92:1068-1078.
    >> Share

  260. WAHIDIYAT PA, Sekarsari D, Adnani NB, Putriasih SA, et al
    Association of pancreatic MRI R2* with blood glucose and cardiac MRI R2* among thalassemia major patients in Indonesia.
    Am J Hematol. 2017;92:E620-E621.
    >> Share

  261. AL-RIYAMI AZ, Iolascon A, Al-Zadjali S, Andolfo I, et al
    Targeted next generation sequencing identifies a novel beta-spectrin gene mutation A2059P in two Omani children with hereditary pyropoikilocytosis.
    Am J Hematol. 2017;92:E607-E609.
    >> Share

    September 2017
  262. ESTEPP JH, Smeltzer MP, Kang G, Li C, et al
    A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.
    Am J Hematol. 2017 Sep 14. doi: 10.1002/ajh.24906.
    >> Share

  263. ASARE EV, Olayemi E, Boafor T, Dei-Adomakoh Y, et al
    Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting.
    Am J Hematol. 2017;92:872-878.
    >> Share

  264. BIALKOWSKI W, Kiss JE, Wright DJ, Cable R, et al
    Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.
    Am J Hematol. 2017;92:851-857.
    >> Share

  265. BARSHTEIN G, Goldschmidt N, Pries AR, Zelig O, et al
    Deformability of transfused red blood cells is a potent effector of transfusion-induced hemoglobin increment: A study with beta-thalassemia major patients.
    Am J Hematol. 2017;92:E559-E560.
    >> Share

  266. SOOD R, Jiramongkolchai K, Streiff M, Gonzalez C, et al
    Look into my eyes: An unusual first presentation of sickle cell disease.
    Am J Hematol. 2017;92:968-971.
    >> Share

  267. SIOW W, Matthey F, Bain BJ
    The significance of irregularly contracted cells and hemighosts in sickle cell disease.
    Am J Hematol. 2017;92:966-967.
    >> Share

    August 2017
  268. BODDU P, Garcia-Manero G, Ravandi F, Borthakur G, et al
    Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience.
    Am J Hematol. 2017 Aug 29. doi: 10.1002/ajh.24897.
    >> Share

    July 2017
  269. ALVAREZ O, Nottage K, Simpson LM, Wood J, et al
    Kidney Function of Transfused Children with Sickle Cell Anemia: Baseline Data from the TWiTCH Study with Comparison to Non-Transfused Cohorts.
    Am J Hematol. 2017 Jul 25. doi: 10.1002/ajh.24871.
    >> Share

  270. HABARA AH, Shaikho EM, Steinberg MH
    Fetal Hemoglobin in Sickle Cell Anemia: The Arab-Indian Haplotype and New Therapeutic Agents.
    Am J Hematol. 2017 Jul 24. doi: 10.1002/ajh.24872.
    >> Share

  271. WITZIG TE, Zinzani PL, Habermann TM, Tuscano JM, et al
    Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma.
    Am J Hematol. 2017 Jul 11. doi: 10.1002/ajh.24854.
    >> Share

  272. YEE MEM, Lane PA, Archer DR, Joiner CH, et al
    Estimation of Glomerular Filtration Rate Using Serum Cystatin C and Creatinine in Adults with Sickle Cell Anemia.
    Am J Hematol. 2017 Jul 3. doi: 10.1002/ajh.24840.
    >> Share

  273. GLASSBERG J, Minnitti C, Cromwell C, Cytryn L, et al
    Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.
    Am J Hematol. 2017;92:622-631.
    >> Share

    June 2017
  274. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Barau C, et al
    Elevated soluble alpha-hemoglobin pool in Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 24. doi: 10.1002/ajh.24835.
    >> Share

  275. KASTHURI RS, Montifar M, Nelson J, Kim H, et al
    Prevalence and Predictors of Anemia in Hereditary Hemorrhagic Telangiectasia.
    Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
    >> Share

  276. SHAIKHO EM, Farrell JJ, Alsultan A, Sebastiani P, et al
    Genetic Determinants of HbF in Saudi Arabian and African Benin Haplotype Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 13. doi: 10.1002/ajh.24822.
    >> Share

  277. QUINN CT, Saraf SL, Gordeuk VR, Fitzhugh CD, et al
    Losartan for the Nephropathy of Sickle Cell Anemia: A Phase-2, Multi-Center Trial.
    Am J Hematol. 2017 Jun 7. doi: 10.1002/ajh.24810.
    >> Share

  278. GOMPERTS E, Belcher JD, Otterbein LE, Coates TD, et al
    The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.
    Am J Hematol. 2017;92:569-582.
    >> Share

    Thalassemia: Yesterday, Today, Tomorrow.
    Am J Hematol. 2017;92:490-492.
    >> Share

  280. BALDINI M, Mancarella M, Cassinerio E, Marcon A, et al
    Adrenal insufficiency: An emerging challenge in thalassemia?
    Am J Hematol. 2017;92:E119-E121.
    >> Share

  281. BRENNAN Y, Curnow J, Favaloro EJ
    2B or not 2B? A prothrombotic tendency masquerading as a bleeding disorder.
    Am J Hematol. 2017;92:584-590.
    >> Share

  282. ANDERSON N, Eckman JR, Ballas SK
    Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography.
    Am J Hematol. 2017;92:E110-E112.
    >> Share

  283. RIVERA A, Vandorpe DH, Shmukler BE, Gallagher DR, et al
    Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc.
    Am J Hematol. 2017;92:E108-E110.
    >> Share

  284. ROUMI JE, Moukhadder HM, Graziadei G, Pennisi M, et al
    Pregnancy in beta-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
    Am J Hematol. 2017;92:E96-E99.
    >> Share

  285. LAMBERT MP, Witmer CM, Kwiatkowski JL
    Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.
    Am J Hematol. 2017;92:E88-E91.
    >> Share

  286. MINNITI CP, Vichinsky E
    Lifespan care in SCD: Whom to transition, the patients or the health care system?
    Am J Hematol. 2017;92:487-489.
    >> Share

    May 2017
  287. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    A follow-up on Desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 May 31. doi: 10.1002/ajh.24806.
    >> Share

  288. TAHER AT, Origa R, Perrotta S, Kourakli A, et al
    New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
    Am J Hematol. 2017;92:420-428.
    >> Share

  289. HALAWI R, Cappellini MD, Taher A
    A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits.
    Am J Hematol. 2017;92:414-416.
    >> Share

  290. READING NS, Ruiz-Bonilla JA, Christensen RD, Caceres-Perkins W, et al
    A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
    Am J Hematol. 2017;92:474-477.
    >> Share

  291. HALAWI R, Beydoun H, Cappellini MD, Ferla V, et al
    Hematologic malignancies in thalassemia: Adding new cases to the repertoire.
    Am J Hematol. 2017;92:E68-E70.
    >> Share

  292. FURLAN L, Graziadei G, Colombo G, Forzenigo LV, et al
    K. pneumoniae liver abscess following deferoxamine subcutaneous self-injection.
    Am J Hematol. 2017;92:480-481.
    >> Share

  293. ANGELUCCI E, Pilo F, Coates TD
    Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.
    Am J Hematol. 2017;92:411-413.
    >> Share

    April 2017
  294. GALADANCI N, Abdullahi SU, Vance LD, Tabari AM, et al
    Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial).
    Am J Hematol. 2017 Apr 25. doi: 10.1002/ajh.24770.
    >> Share

  295. RAVINDRAN A, Sankaran J, Jacob EK, Kreuter JD, et al
    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
    Am J Hematol. 2017 Apr 24. doi: 10.1002/ajh.24765.
    >> Share

  296. COURONNE L, Tertian G, Boutron A, Picard V, et al
    A Somatic Mosaicism in the G6PD Gene Inducing a Late Onset Chronic non Spherocytic Hemolytic Anemia.
    Am J Hematol. 2017 Apr 10. doi: 10.1002/ajh.24760.
    >> Share

  297. HANSEN JW, Sandholdt H, Siersma V, Orskov AD, et al
    "Anemia is present years before myelodysplastic syndrome diagnosis - results from the pre-diagnostic period".
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24757.
    >> Share

  298. GRALL M, Azoulay E, Galicier L, Provot F, et al
    Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.
    Am J Hematol. 2017;92:381-387.
    >> Share

  299. LI LY, Liu ZY, Liu H, Liu CY, et al
    Deep sequencing of whole genome exon in paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 2017;92:E51-E53.
    >> Share

  300. STEHOUWER N, Edge P, Katie Park B, Piccone C, et al
    Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Am J Hematol. 2017;92:E40-E42.
    >> Share

  301. MANU PEREIRA MD, Ropero P, Loureiro C, Vives Corrons JL, et al
    Low affinity hemoglobinopathy (Hb Vigo) due to a new mutation of beta globin gene (c200 A>T; Lys>Ile). A cause of rare anemia misdiagnosis.
    Am J Hematol. 2017;92:E38-E40.
    >> Share

    March 2017
  302. NASSIN ML, Vergilio JA, Heeney MM, LaBelle JL, et al
    Neonatal Anemia: Revisiting the Enigmatic Pyknocyte.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24731.
    >> Share

  303. LEWEN MO, Kavanagh PL, Sobota AE
    A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24727.
    >> Share

  304. MEKONTSO DESSAP A, Cecchini J, Chaar V, Marcos E, et al
    Telomere attrition in sickle cell anemia.
    Am J Hematol. 2017 Mar 15. doi: 10.1002/ajh.24721.
    >> Share

  305. FARRUGGIA P, Puccio G, Ramenghi U, Colombatti R, et al
    Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: A retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Am J Hematol. 2017 Mar 6. doi: 10.1002/ajh.24713.
    >> Share

  306. PATNAIK MM, Tefferi A
    Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Am J Hematol. 2017;92:297-310.
    >> Share

  307. SALIBA AN, Musallam KM, Cappellini MD, Graziadei G, et al
    Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.
    Am J Hematol. 2017;92:E35-E37.
    >> Share

  308. SCHOTTEN N, Laarakkers CM, Roelofs RW, Origa R, et al
    EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.
    Am J Hematol. 2017;92:E29-E31.
    >> Share

  309. BARCELLINI W, Fattizzo B, Zaninoni A, Valli V, et al
    Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes.
    Am J Hematol. 2017;92:E26-E29.
    >> Share

  310. GRAFFEO L, Vitrano A, Giambona A, Scondotto S, et al
    The heterozygote state for beta-thalassemia detrimentally affects health outcomes.
    Am J Hematol. 2017;92:E23-E25.
    >> Share

  311. SOKOL KA, Veluswamy RR, Zimmerman BS, Tummalapalli SL, et al
    Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus.
    Am J Hematol. 2017;92:322.
    >> Share

    February 2017
  312. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    Desiderosmia (olfactory craving): A novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 Feb 27. doi: 10.1002/ajh.24706.
    >> Share

  313. LEAF RK, O'Brien KL, Leaf DE, Drews RE, et al
    Autoimmune hemolytic anemia in a young man with acute hepatitis E infection.
    Am J Hematol. 2017 Feb 23. doi: 10.1002/ajh.24699.
    >> Share

  314. WHIPPLE NS, Schwartz JR, Nottage KA
    DAT-positive Plasmodium ovale malaria presenting in a child with sickle cell anemia.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24691.
    >> Share

  315. BENNANI NN, LaPlant BR, Ansell SM, Habermann TM, et al
    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24671.
    >> Share

  316. ALELUIA MM, Santiago RP, da Guarda CC, Fonseca TC, et al
    Genetic Modulation of Fetal Hemoglobin in Hydroxyurea-Treated Sickle Cell Anemia.
    Am J Hematol. 2017 Feb 13. doi: 10.1002/ajh.24680.
    >> Share

  317. CHATURVEDI S, Labib Ghafuri D, Kassim A, Rodeghier M, et al
    Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
    Am J Hematol. 2017;92:125-130.
    >> Share

  318. WRAY K, Allen A, Evans E, Fisher C, et al
    Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.
    Am J Hematol. 2017;92:196-203.
    >> Share

  319. VAN TUIJN CF, Sins JW, Fijnvandraat K, Biemond BJ, et al
    Daily pain in adults with sickle cell disease-a different perspective.
    Am J Hematol. 2017;92:179-186.
    >> Share

  320. DELVILLE M, Manceau S, Ait Abdallah N, Stolba J, et al
    Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.
    Am J Hematol. 2017;92:136-140.
    >> Share

    January 2017
  321. DERMAN R, Roman E, Modiano MR, Okam MM, et al
    A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Am J Hematol. 2017 Jan 4. doi: 10.1002/ajh.24633.
    >> Share

  322. DAI Y, Sangerman J, Nouraie M, Faller AD, et al
    Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.
    Am J Hematol. 2017;92:E10-E11.
    >> Share

    December 2016
  323. JACOB SA, Novelli EM, Isenberg JS, Garrett ME, et al
    Thrombospondin-1 Gene Polymorphism is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia.
    Am J Hematol. 2016 Dec 29. doi: 10.1002/ajh.24635.
    >> Share

  324. RICCHI P, Costantini S, Spasiano A, Di Matola T, et al
    Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24622.
    >> Share

  325. BAIN BJ
    Howell-Jolly bodies in acute hemolytic anemia.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24624.
    >> Share

    October 2016
  326. GOODNOUGH LT, Comin-Colet J, Leal-Noval S, Ozawa S, et al
    Management of Anemia in Patients with Congestive Heart Failure.
    Am J Hematol. 2016 Oct 25. doi: 10.1002/ajh.24595.
    >> Share

  327. QUARMYNE MO, Dong W, Theodore R, Anand S, et al
    Hydroxyurea Effectiveness in Children and Adolescents with Sickle Cell Anemia: A Large Retrospective, Population-Based Cohort.
    Am J Hematol. 2016 Oct 19. doi: 10.1002/ajh.24587.
    >> Share

  328. MICHEL M, Terriou L, Roudot-Thoraval F, Hamidou M, et al
    A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study).
    Am J Hematol. 2016 Oct 3. doi: 10.1002/ajh.24570.
    >> Share

    September 2016
  329. QUINN CT, Smith EP, Arbabi S, Khera PK, et al
    Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.
    Am J Hematol. 2016 Sep 20. doi: 10.1002/ajh.24562.
    >> Share

  330. DONKER AE, Schaap CC, Novotny VM, Smeets R, et al
    Iron Refractory Iron Deficiency Anemia (IRIDA): A heterogeneous disease that is not always iron refractory.
    Am J Hematol. 2016 Sep 19. doi: 10.1002/ajh.24561.
    >> Share

  331. DEITERING S, Anslemo L, Burnett A, Jakeman B, et al
    Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia.
    Am J Hematol. 2016 Sep 15. doi: 10.1002/ajh.24555.
    >> Share

    May 2016
  332. KROPSHOFER G, Sopper S, Steurer M, Schwinger W, et al
    Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.
    Am J Hematol. 2016 May 30. doi: 10.1002/ajh.24436.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016